Results 11 to 20 of about 15,999,574 (258)

The effect of depressive symptoms on pain in a substance-using population with persistent pain: a cross-sectional cohort study

BMC Psychiatry, 2021
Background In light of the ongoing opioid overdose crisis, there is an urgent need for research on the impacts of mental health among people presenting with concurrent pain and substance use.
Pauline Voon, Jin Cheol Choi, Kanna Hayashi, M-J Milloy, Jane Buxton, Thomas Kerr   +5 more
doaj   +2 more sources

Experiences of violence during the COVID-19 pandemic among people who use drugs in a Canadian setting: a gender-based cross-sectional study

BMC Public Health, 2023
Objectives People who use drugs (PWUD) experience disproportionately high rates of violent victimization. Emerging research has demonstrated that the COVID-19 pandemic has exacerbated violence against some priority populations (e.g., women), however ...
Anmol Swaich, Lindsey Richardson, Zishan Cui, Kora DeBeck, M-J Milloy, Thomas Kerr, Kanna Hayashi   +6 more
doaj   +1 more source

Quality of life and substance use in Lebanese medical students [PDF]

, 2023
Background: Substance use is prevalent among medical students and could affect their academic performance. This study aimed to determine whether a relationship exists between quality of life and substance use among medical students in Lebanon.
Serhan, Fatima G., Mariana Helou, Souheil Hallit, Helou, Mariana, Akl, Michel, Soufia, Michel, Mouawad, Yara, Georges-Alain Al Tekle, Hallit, Souheil R., Michel Akl, Michel Soufia, Fatima Serhan, Al Tekle, Georges Alain, Yara Mouawad   +13 more
core   +1 more source

The impact of the COVID-19 pandemic on access to supervised consumption programs

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Supervised consumption sites (SCS) and overdose prevention sites (OPS) have been increasingly implemented in response to the ongoing overdose epidemic in Canada. Although there has been a dramatic increase in overdose deaths since the start of
Emili Gubskaya, Mary Clare Kennedy, Kanna Hayashi, Zishan Cui, M-J Milloy, Thomas Kerr   +5 more
doaj   +1 more source

The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting

Addiction Science & Clinical Practice, 2021
Background While patient-reported treatment dissatisfaction is considered an important factor in determining the success of substance use disorder treatment, the levels of dissatisfaction with opioid agonist therapies (OAT) and its relationship with the ...
Lindsay Mackay, Thomas Kerr, Nadia Fairbairn, Cameron Grant, M.-J. Milloy, Kanna Hayashi   +5 more
doaj   +1 more source

Factors associated with drug checking service utilization among people who use drugs in a Canadian setting

Harm Reduction Journal, 2020
Background The United States and Canada are amidst an opioid overdose crisis, with the Canadian province of British Columbia (BC) among the hardest hit. In response, drug checking services (DCS) have been introduced in this setting as a novel pilot harm ...
Viseth Long, Jaime Arredondo, Lianping Ti, Cameron Grant, Kora DeBeck, M-J Milloy, Mark Lysyshyn, Evan Wood, Thomas Kerr, Kanna Hayashi   +9 more
doaj   +1 more source

The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders

, 2021
Background: In the Canadian Province of British Columbia (BC), the BC Mental Health Act permits involuntary care for treating mental disorders. However, the Act has also been applied to provide involuntary care to individuals with a primary substance ...
Winston, Mark L., Pakhomova, Tatiana E., Thompson, Erica, MacPherson, Donald, Small, Will, Lou, Hayami, Vigo, Daniel V., Chau, Leena W., Erickson, Margaret, Margaret Erickson, Tatiana Pakhomova, Donald MacPherson, Mark L. Winston, Hayami Lou, Leena W. Chau, Erica Thomson, Daniel Vigo, Will Small   +17 more
core   +1 more source

The impact of PSTD on service access among people who use drugs in Vancouver, Canada

Substance Abuse Treatment, Prevention, and Policy, 2021
Background Settings throughout the United States and Canada are contending with high rates of drug-related overdose. This in turn has prompted efforts to more effectively engage people who use drugs (PWUD) in treatment and care.
Annemarie Goytan, William Lee, Huiru Dong, Kanna Hayashi, M. J. Milloy, Thomas Kerr   +5 more
doaj   +1 more source

Polysubstance use poisoning deaths in Canada: an analysis of trends from 2014 to 2017 using mortality data

BMC Public Health, 2022
Background Over the past decade, rates of drug poisoning deaths have increased dramatically in Canada. Current evidence suggests that the non-medical use of synthetic opioids, stimulants and patterns of polysubstance use are major factors contributing to
Sarah Konefal, Adam Sherk, Bridget Maloney-Hall, Matthew Young, Pam Kent, Emily Biggar   +5 more
doaj   +1 more source

Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada

Substance Abuse Treatment, Prevention, and Policy, 2022
Background Novel public health interventions are needed to address the toxic drug supply and meet the needs of people who use drugs amidst the overdose crisis.
Annie Foreman-Mackey, Bernie Pauly, Andrew Ivsins, Karen Urbanoski, Manal Mansoor, Geoff Bardwell   +5 more
doaj   +1 more source